Research and Development Trend of China Independent Clinical Laboratory Market, (Sample)

Transcription

1 Research and Development Trend China Independent Clinical Laboratory Market, (Sample) Huidian Research Publication Date: June 2013

2 4. Development China Independent Clinical Laboratory Industry 4.1 Status Quo China Independent Clinical Laboratory Market Market Capacity As 2010, the market scale independent clinical laboratory was CNY 1.2 billion, accounting for about 1% market shares in clinical laboratory: according to Frost& Sullivan s statistical data, sales value China clinical laboratory industry was CNY 170 million in 2006, increased to CNY 1.2 billion in 2010, and annual compound growth rate reached 63%. While the growth was slightly declined in 2011 and 2012, with annual growth rate remained about 45%, market scale was about CNY 2.5 billion as At present, it only accounts for about 1.5% market shares in clinical laboratory industry. Fig. 9 Market Scale China Independent Laboratory, Unit: CNY 100 million Source: Huidian Research Competitive Landscape (B) Overall Competition Domestic Market

3 1. Hospitals have a dominated position in clinical laboratory service market 2. Different regions have non-unified competition degree 3. Competition dispersed across the whole country, while concentrated on regions 4. Oligopoly Pattern At present, China independent clinical laboratory industry mainly is guided by local enterprises, with having over 30 qualified companies. And chain enterprises account for more 70% market shares, mainly represented by Kingmed, Adicon and DAAN Gene, forming the oligopoly. Under the background new medical reform, independent clinical laboratory industry will further expand so as to enter rapid-growth period. During this period, increasing new entrants will step into this industry, chain enterprises and solo independent laboratory will coexist. But in the long run, chain enterprises are equipped with the capacities large-scale purchase and standard management and administration for reducing production costs; service network layout will obtain brand effect for attracting customers. However, the service solo independent laboratory is limited within 400 kilometers, customer resources are inclined to be saturated. In addition, it will drop out the market along with losses because declined prices. Thus chain enterprises are expected to be still prosperous. Tab.12 Market Shares and Distribution Four China Independent Clinical Laboratories Kingmed Adicon Dian Diagnostics DAAN Gene Time Establishment (independent clinical laboratory started in 2004) 2007 Headquarters Guangzhou Hangzhou Hangzhou Guangzhou Staff Customers unknown unknown Market Shares 20% 15%-20% 15%-20% 10%-15% Labs (3 labs under construction) Source: Each Company s Annual Reports 9(3 labs under construction) Through comparing testing project reserves, layout service network station and management and administration capability in domestic chain enterprises, Huidian Research holds a view Kingmed owns absolute competitive advantages and will keep its leading position in industry due to high-end project reserves and many

4 laboratories are widely distributed; Adicon and Dian placed on the second, Adicon has high-end project reserves and strict quality control standards, while Dian owns differentiation competitive advantages such as level-to-level administration laboratories, increase output and agency + service mode for reducing purchasing costs etc.; DAAN Gene started late (2007), so it is slightly inferior to the other three enterprises. Table Contents 1. Overview Independent Clinical Laboratory 1.1 Definition 1.2 Business Pattern 1.3 Technological Level and Technical Characteristics 2. Development History Independent Clinical Laboratory Industry 2.1 Development Status Quo Foreign Independent Clinical Laboratory Background Development American Independent Clinical Laboratory 2.2 Development China s Independent Clinical Laboratory 3. Development Environment Independent Clinical Laboratory 3.1 Cost Control in Public Hospital 3.2 Increased Treatments in Basic Medical Institutions 3.3 Rapid Development Private Hospitals 3.4 Industry Supervision System 3.5 Policies and Major Regulations 4. Development China Independent Clinical Laboratory Industry 4.1 Status Quo China Independent Clinical Laboratory Market Market Capacity Competitive Landscape Marketization Degree Changing Trend Prit and Reasons Michael Porter s Five Forces Model 4.2 Market Supply and Demand China Independent Clinical Laboratory and Influencing Factors 4.3 Upstream Industry and Downstream Industry Upstream Industry s Impact on Independent Clinical Laboratory Industry Downstream Industry s Impact on Independent Clinical Laboratory Industry 4.4 Barriers to Entry Barrier Access Quality Control Technical Barrier

5 4.4.4 Pressional Talents 4.5 Development Factors Favorable Factors Negative Factors 5. Key Enterprises China Independent Clinical Laboratory 5.1 Kingmed Diagnostics Company Prile Service Network Business Performance Management and Administration Mode Future Development Strategy 5.2 Dian Diagnostics Company Prile Business Performance Business Composition Analysis Major Suppliers Competitive Advantages Future Development Strategy and Business Plan in DAAN Gene Co., Ltd Company Prile Business Performance Revenue Composition Suppliers Competitive Advantages 5.4 Adicon Company Prile Business Performance Future Development Strategy 6. Future Development China Independent Clinical Laboratory 6.1 Future Development Trend th Five-Year Plan New Medical Reform Policy Brings Opportunities Continuous Rapid Growth Medical Service Industry Promote Independent Clinical Laboratory Service Industry New Diagnostic Techniques Motive Independent Clinical Laboratory Service Industry 6.2 Challenges and Opportunities 6.3 Market Shares and Structure Upgrade